Business Context and Reporting Period
Company: Viewbix Inc. (Note: Request metadata listed "Quantum X Labs Inc.", but the filing text identifies the registrant as Viewbix Inc.)
Filing Type: Form 8-K (Current Report)
Date: July 22, 2024
Context: The Company entered into two amended and restated credit facility agreements to secure financing contingent upon the uplisting of its common stock to a national securities exchange.
Key Financial Metrics and Obligations
This filing details the creation of direct financial obligations rather than reporting historical revenue or profit metrics.
- First Credit Facility: Total commitment of $1,000,000 plus $530,657 in prior outstanding debt (Total "First Loan Amount" approx. $1.53M).
- Second Credit Facility: Total commitment of $2,500,000.
- Interest Rate: Both facilities accrue interest at 12% per annum.
- Interest Payment Method: Payable in shares of common stock and warrants rather than cash.
- Conversion Price: $0.25 per share for debt conversion and warrant exercise.
- Liquidity Status: The filing does not provide current cash balances or liquidity ratios.
Material Changes and Transaction Details
The Company amended prior facility agreements (dated June 18, 2024, and July 4, 2024) with the following material terms:
First Facility Terms
- Drawdown Schedule: $350,000 drawn previously; $150,000 upon filing of registration statement; $500,000 upon effectiveness of the uplisting.
- Conversion Trigger: Upon uplisting, $662,957 of the loan amount converts to stock and warrants. The remainder remains outstanding until maturity or election to convert.
- Lead Lender Compensation: 200,000 shares, a warrant for 200,000 shares ($0.25 strike), and a warrant for 2,500,000 shares ($1.00 strike).
Second Facility Terms
- Drawdown Schedule: $50,000 drawn previously; $50,000 upon uplisting; remaining $2.4M available for quarterly drawdowns post-uplisting.
- Conversion Trigger: Upon uplisting, $100,000 converts to stock and warrants. The remainder is available for drawdown or repayment upon term lapse.
- Lender Fee: 125,000 shares and a warrant for 1,000,000 shares ($0.25 strike).
Guidance, Risks, and Contingencies
Contingencies: The full utilization of both credit facilities and specific conversion events are contingent upon the "Uplist" (uplisting of shares to a national securities exchange). If the uplisting does not occur, the drawdown schedules and conversion mechanisms may not be triggered as planned.
Risks:
- Dilution: Significant issuance of shares and warrants is required for interest payments, fees, and principal conversion.
- Repayment Obligation: If the Second Facility Term lapses without a $2.0 million financing transaction or full drawdown, the outstanding amount must be repaid in cash.
- Forward-Looking Statements: The Company explicitly states that the uplisting is subject to conditions and may not occur.
Investor Verification Checklist
- Verify the current status of the "Uplist" application and whether the registration statement for the resale of securities has been filed within the required 30 days.
- Confirm the exact number of shares currently outstanding to assess the dilution impact of the 734,715+ shares issued for interest and the additional conversion units.
- Review the "First Facility Prior Loan Amount" ($530,657) to understand the total debt burden carried over from the June 2024 agreement.
- Assess the Company's ability to repay the Second Facility in cash if the $2.0 million financing transaction or full drawdown does not occur within 12 months.